Monitoring Agency Report issued by CRISIL Ratings Limited for the utilization of funds raised through Preferential Issue as approved by the Board and members of the Company in their respective meetings held on June 18, 2024 and July 13, 2024, for quarter ended December 31, 2025
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zota Health Care has submitted the Monitoring Agency Report issued by CRISIL Ratings Limited, covering the utilization of funds raised through a Preferential Issue. The issue was approved by the Board and shareholders in meetings held on June 18, 2024 and July 13, 2024. This particular report pertains to the quarter ended December 31, 2025. The filing confirms regulatory compliance with SEBI's requirement for a monitoring agency to track end-use of funds raised through preferential allotments.
This is a routine compliance filing and does not indicate any new capital raising or change in business outlook. Shareholders should look for the actual utilization details in the report to assess whether proceeds are being deployed as originally disclosed.